MedTrace Logo

Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer

NCT00900523 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2013-04-18

No results posted yet for this study

Summary

RATIONALE: Measuring the amount of prostaglandin metabolite in urine samples and studying tissue samples in the laboratory from patients with ovarian cancer may help doctors identify and learn more about biomarkers related to ovarian cancer and may help the study of cancer in the future.

PURPOSE: This laboratory study is measuring the amount of prostaglandin metabolite in urine samples from patients with ovarian cancer.

Conditions

Interventions

GENETIC

protein expression analysis

protein expression analysis

OTHER

immunohistochemistry

immunohistochemical staining of tumor tissue to measure COX-1 and COX-2 levels

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Vanderbilt-Ingram Cancer Center

    lead OTHER

Principal Investigators

  • Marta Crispens, MD · Vanderbilt-Ingram Cancer Center

Eligibility

Min Age
17 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2007-07-31
Completion
2008-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00900523 on ClinicalTrials.gov